Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Recruiting · NCT05028829 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Phase 2 | 2026-10-07 | NCT05028829 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Raymond Chung | 1 |
| University of Texas Southwestern Medical Center | 295 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| University of Texas Southwestern Medical Center | Dallas | United States | 249 |